COVID-19-DM: The Effect of COVID-19 on Diabetes Mellitus
Sponsor
Uşak University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04592055
Collaborator
(none)
500
1
15.4
32.5
Study Details
Study Description
Brief Summary
The study aimed to evaluate the effect of SARS-COV-2 infection on metabolic status in patients with diabetes mellitus. Patients' HbA1c levels before and after SARS-COV-2 infection will be evaluated.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
In this time pediods, all patients with RT-PCR positive for SARS-COV-2 will be analysed for the presence of diabetes mellitus. Previous HbA1c levels will be obtained from hospital records. In these patients, previous A1c levels and A1c levels 3 months after the SARS-COV-2 infection will be compared.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
500 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
The Effect of COVID-19 on the Glycemic Control in Patients With Diabetes Mellitus
Actual Study Start Date
:
Mar 20, 2020
Actual Primary Completion Date
:
Oct 15, 2020
Anticipated Study Completion Date
:
Jul 1, 2021
Outcome Measures
Primary Outcome Measures
- A1c [6 months (3 months before and after COVID-19]
the change in A1c levels
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
- All hospitalised diabetic patients with RT-PCR- positive for SARS-COV-2 will be enrolled.
Exclusion Criteria:
- The absence of diabetes mellitus RT-PCR- negative for SARS-COV-2 Non-hospitalised patients
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Usak University Training and Research Hospital | Usak | Turkey | 64200 |
Sponsors and Collaborators
- Uşak University
Investigators
- Principal Investigator: Cevdet Duran, Prof, Uşak University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Uşak University
ClinicalTrials.gov Identifier:
NCT04592055
Other Study ID Numbers:
- UU-DM002
First Posted:
Oct 19, 2020
Last Update Posted:
May 4, 2021
Last Verified:
May 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: